A new role for Biofoundries in rapid prototyping, development, and validation of automated clinical diagnostic tests for SARS-CoV-2 (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.05.02.20088344
Publication URI: http://dx.doi.org/10.1101/2020.05.02.20088344
Type: Preprint